Polymers for medical and tissue engineering applications

Journal of Chemical Technology and Biotechnology

Volumn 89, Issue 12, 2014, Pages 1793-1810

  Ozdil, Deniz ^a   Aydin, Halil Murat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Polymers; Scaffolds; Tissue engineering; Tissues and organs

Indexed keywords

BIOCOMPATIBILITY; FUNCTIONAL POLYMERS; HISTOLOGY; INDUSTRIAL RESEARCH; MEDICAL APPLICATIONS; POLYMERS; REPAIR; SCAFFOLDS; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE ENGINEERING;

MANUFACTURING TECHNIQUES; MEDICAL RESEARCH; POLYMERIC BIOMATERIALS; SYNTHETIC POLYMERS; TISSUE ENGINEERING APPLICATIONS;

TISSUE REGENERATION;

ALBUMIN; ALGINIC ACID; CHEMICAL COMPOUND; CHITIN; CHITOSAN; CHONDROTIN SULPHATE; COLLAGEN; FIBRIN; HYALURONIC ACID; MACROGOL; POLY(3 HYDROXYBUTYRIC ACID); POLY(DIOXANONE); POLY(GLYCEROL SEBACATE); POLY(ORTHO ESTER); POLY(PHOSPHAZENES); POLYANHYDRIDE; POLYCAPROLACTONE; POLYETHERETHERKETONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; POLYURETHAN; SULFATE; UNCLASSIFIED DRUG;

ADHESION; ARTICULAR CARTILAGE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMEDICAL ENGINEERING; BONE REMODELING; CELL MOTILITY; CLICK CHEMISTRY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; MICHAEL ADDITION; POLYMERIZATION; REVIEW; TEMPERATURE; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND HEALING;

EID: 85027925152     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.4505     Document Type: Review

References (345)

1. Lakshmi SN, Laurencin CT, Biodegradable polymers as biomaterials. Prog Polym Sci 32:762-798 (2007).
2. Yannas IV, Classes of Materials used in Medicine: Natural Materials, ed by B. D. Ratner ASH, F an. J . Schoen and Lemons J. Elsevier Academic Press; San Diego, CA, USA (2004).
3. Hahn SK, Jelacic S, Maier RV, Stayton PS and Hoffman AS, Anti-inflammatory drug delivery from hyaluronic acid hydrogels. J Biomater Sci - Polym E 15:1111-1119 (2004).
4. Seidlits SK CTD, Petersen RR, Shear JB, Suggs L J and Schmidt CE, Fibronectin-hyaluronic acid composite hydrogels for three-dimensional endothelial cell culture. Acta Biomater 7:2401-2409 (2011).
5. Kim M, Optimization of macromer density in human MSC-laden hyaluronic acid (HA) hydrogels, in Bioengineering Conference (NEBEC), 2012 38th Annual Northeast (2012); 16-18 March 2012; Philadelphia, PA: IEEE; 211-212 (2012).
6. Park JK, Shim J-H, Kang KS, Yeom J, Jung HS, Kim JY, Lee KH, Kim T-H, Kim S-Y, Cho D-W and Hahn SK, Solid free-form fabrication of tissue-engineering scaffolds with a poly(lactic-co-glycolic acid) grafted hyaluronic acid conjugate encapsulating an intact bone morphogenetic protein-2/poly(ethylene glycol) complex. Adv Function Mater 21:2906-2912 (2011).
7. Chung C, Erickson IE, Mauck RL and Burdick JA, Differential Behavior of Auricular and Articular Chondrocytes in Hyaluronic Acid Hydrogels. Tissue Eng Part A 14:1121-1131 (2008).
8. Knudson W, Loeser RF, CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci 59:36-44 (2002).
9. Tool BP, Hyaluronan in morphogenesis. Semin Cell Dev Biol 12:79-87 (2001).
10. Goodstone NJ, Cartwright A and Ashton B, Effects of high molecular weight hyaluronan on chondrocytes cultured within a resorbable gelatin sponge. Tissue Eng 10:621-631 (2004).
11. Kawasaki K, Ochi M, Uchio Y, Adachi N and Matsusaki M, Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 179:142-148 (1999).
12. Duflo S, Thibeault SL, Li WH, Shu XZ and Prestwich G, Effect of a synthetic extracellular matrix on vocal fold lamina propria gene expression in early wound healing. Tissue Eng 12:3201-3207 (2006).
13. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, et al., Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26:58-68 (2007).
14. Birk DE and Bruckner P, Collagen suprastructures. Top Curr Chem 247:185-205 (2005).
15. Francis G and Thomas J, Isolation and chemical characterization of collagen in bovine pulmonary tissues. Biochem J 145:287-297 (1975).
16. Lee CH, Singla A and Lee Y, Biomedical applications of collagen. Int J Pharm 221:1-22 (2001).
17. Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR, Di Lullo GA, et al., Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 283:21187-21197 (2008).
18. Rich A, Solving the structure of collagen. Self-assembling peptide systems in biology. Med Eng 235-241 (2001).
19. Voge CM, Kariolis M, MacDonald RA and Stegemann JP, Directional conductivity in SWNT-collagen-fibrin composite biomaterials through strain-induced matrix alingment. J Biomed Mater Res A 86A:269-277 (2008).
20. Seliktar D, Black RA, Vito RP and Nerem RM, Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 28:351-362 (2000).
21. Isenberg BC and Tranquillo RT, Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann Biomed Eng 31:937-949 (2003).
22. Heino J, The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 19:319-323 (2000).
23. White DJ, Puranen S, Johnson MS and Heino J, The collagen receptor subfamily of the integrins. Int J Biochem Cell B 36:1405-1410 (2004).
24. Sarikaya B and Aydin HM, Development of collagen/beta-TCP based synthetic bone grafts. J Tiss Eng Reg Med 8:410-410 (2014).
25. Aydin HM, Yang Y, Kohler T, El Haj A, Müller R, Pişkin E, Interaction of osteoblasts with macroporous scaffolds made of PLLA/PCL blends modified with collagen and hydroxyapatite. Adv Eng Mater 11:B83-B88 (2009).
26. Kojima K, Okamoto Y, Kojima K, Miyatake K, Fujise H, Shigemasa Y, et al., Effects of chitin and chitosan on collagen synthesis in wound healing. J Vet Med Sci 66:1595-1598 (2004).
27. Islam A and Yasin T, Controlled delivery of drug from pH sensitive chitosan/poly (vinyl alcohol) blend. Carbohyd Polym 88:1055-1060 (2012).
28. Ren DW, Yi HF, Wang W and Ma XJ, The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. Carbohyd Res 340:2403-2410(2005).
29. Li DH, Liu LM, Tian KL, Liu JC and Fan XQ, Synthesis, biodegradability and cytotoxicity of water-soluble isobutylchitosan. Carbohyd Polym 67:40-45 (2007).
30. Xia WS, Liu P and Liu J, Advance in chitosan hydrolysis by non-specific cellulases. Bioresource Technol 99:6751-6762 (2008).
31. Chen RN, Wang GM, Chen CH, Ho HO and Sheu MT, Development of N, O-(carboxymethyl)chitosan/collagen matrixes as a wound dressing. Biomacromolecules7:1058-1064 (2006).
32. Liu BS, Yao CH and Fang SS, Evaluation of a non-woven fabric coated with a chitosan Bi-layer composite for wound dressing. Macromol Biosci 8:432-440 (2008).
33. Wang JP, Feng SS, Wang S and Chen ZY, Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment. Int J Pharm 400:194-200 (2010).
34. Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, et al., Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Int J Pharm 371:142-147 (2009).
35. Zhang YQ, Chen JJ, Zhang YD, Pan YF, Zhao JF, Ren LF, et al., A novel PEGylation of chitosan nanoparticles for gene delivery. Biotechnol Appl Biochem 46:197-204 (2007).
36. Matsusaki M, Sakaguchi H, Serizawa T and Akashi M, Controlled release of vascular endothelial growth factor from alginate hydrogels nano-coated with polyelectrolyte multilayer films. J Biomat Sci - Polym E18:775-783 (2007).
37. Berger J, Reist M, Mayer JM, Felt O, Peppas NA and Gurny R, Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 57:19-34 (2004).
38. Rodrigues IR, Forte MMD, Azambuja DS and Castagno KRL, Synthesis and characterization of hybrid polymeric networks (HPN) based on polyvinyl alcohol/chitosan. React Funct Polym 67:708-715 (2007).
39. Ma GP, Yang DZ, Li QZ, Wang KM, Chen BL, Kennedy JF, et al., Injectable hydrogels based on chitosan derivative/polyethylene glycol dimethacrylate/N, N-dimethylacrylamide as bone tissue engineering matrix. Carbohyd Polym 79:620-627 (2010).
40. Hsieh CY, Hsieh HJ, Liu HC, Wang DM and Hou LT, Fabrication and release behavior of a novel freeze-gelled chitosan/gamma-PGA scaffold as a carrier for rhBMP-2. Dent Mater 22:622-629 (2006).
41. Di Martino A, Sittinger M and Risbud MV, Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26:5983-5990 (2005).
42. Peng L, Cheng XR, Zhuo RX, Lan J, Wang YN, Shi B, et al., Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering. J Biomed Mater Res A 90A:564-576 (2009).
43. Martins AM, Alves CM, Kasper FK, Mikos AG and Reis RL, Responsive and in situ-forming chitosan scaffolds for bone tissue engineering applications: an overview of the last decade. J Mater Chem 20:1638-1645 (2010).
44. Azhar FO, A ; Salehi, R. Fabrication and characterization of chitosan-gelatin/nanohydroxyapatite-polyaniline composite with potential application in tissue engineering scaffolds. Designed Monom Polym 17:654-667 (2014).
45. Lee SH, DN, Moon JH, Park HN, Ko WK, Bae MS, Lee JB, Park SW, Kim EC, Lee CH, Jung BY and Kwon IK, Chitosan/polyurethane blended fiber sheets containing silver sulfadiazine for use as an antimicrobial wound dressing. J Nanosci Nanotechnol (2014)14:7488-7494.
46. Mekhail M, Jahan K and Tabrizian M, Genipin-crosslinked chitosan/poly-L-lysine gels promote fibroblast adhesion and proliferation. Carbohyd Polym 108:91-98 (2014).
47. Doty HL, Leedy MR, Courtney HS, Haggard WO and Bumgardner JD, Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-2. J Mater Sci - Mater M 25:1449-1459 (2014).
48. Tan CS, Jejurikar A, Rai B, Bostrom T, Lawrie G and Grondahl L, Encapsulation of a glycosaminoglycan in hydroxyapatite/alginate capsules. J Biomed Mater Res A 91A:866-877 (2009).
49. Jay SM, Shepherd BR, Andrejecsk JW, Kyriakides TR, Pober JS and Saltzman WM, Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials 31:3054-3062 (2010).
50. Hahn MS, Teply BA, Stevens MM, Zeitels SM and Langer R, Collagen composite hydrogels for vocal fold lamina propria restoration. Biomaterials 27:1104-1109 (2006).
51. Wang YZ, Kim HJ, Vunjak-Novakovic G and Kaplan DL, Stem cell-based tissue engineering with silk biomaterials. Biomaterials 27:6064-6082 (2006).
52. Kim JH, Kim YS, Kim S, Park JH, Kim K, Choi K, et al., Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release 111:228-234 (2006).
53. Liu XY, Nothias JM, Scavone A, Garfinkel M and Millis JM, Biocompatibility investigation of polyethylene glycol and alginate-poly-l-lysine for islet encapsulation. ASAIO J 56:241-245 (2010).
54. Purcell EK, Singh A and Kipke DR, Alginate composition effects on a neural stem cell-seeded scaffold. Tissue Eng Part C - Me 15:541-550 (2009).
55. Gou ML, Wei XW, Men K, Wang BL, Luo F, Zhao X, et al., PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets 12:1131-1150 (2011).
56. Lim SM, Oh SH, Lee HH, Yuk SH, Im GI and Lee JH, Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering. J Mater Sci - Mater M 21:2593-6000 (2010).
57. Meng X, Li P, Wei Q and Zhang HX, pH sensitive alginate-chitosan hydrogel beads for carvedilol delivery. Pharm Dev Technol 16:22-28 (2011).
58. Wang JZ, Huang XB, Xiao J, Yu WT, Wang W, Xie WY, et al., Hydro-spinning: a novel technology for making alginate/chitosan fibrous scaffold. J Biomed Mater Res A 93A:910-919 (2010).
59. Marsich E, Borgogna M, Donati I, Mozetic P, Strand BL, Salvador SG, et al., Alginate/lactose-modified chitosan hydrogels: a bioactive biomaterial for chondrocyte encapsulation. J Biomed Mater Res A 84A:364-376 (2008).
60. Wang Q, Jamal S, Detamore MS and Berkland C, PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. J Biomed Mater Res A 96A:520-527 (2011).
61. Qi XP, Ye JD and Wang YJ, Alginate/poly (lactic-co-glycolic acid)/calcium phosphate cement scaffold with oriented pore structure for bone tissue engineering. J Biomed Mater Res A 89A:980-987 (2009).
62. Qi J, Chen AM, You HB, Li KP, Zhang D and Guo FJ, Proliferation and chondrogenic differentiation of CD105-positive enriched rat synovium-derived mesenchymal stem cells in three-dimensional porous scaffolds. Biomed Mater 6:015006 (2011).
63. Olmez SS, Korkusuz P, Bilgili H and Senel S, Chitosan and alginate scaffolds for bone tissue regeneration. Pharmazie 62:423-431 (2007).
64. Wittmer CR, Phelps JA, Lepus CM, Saltzman WM, Harding MJ and Van Tassel PR, Multilayer nanofilms as substrates for hepatocellular applications. Biomaterials 29:4082-4090 (2008).
65. Jin XB, Sun YS, Zhang K, Wang J, Shi TP, Ju XD, et al., Tissue engineered cartilage from hTGF beta 2 transduced human adipose derived stem cells seeded in PLGA/alginate compound in vitro and in vivo. J Biomed Mater Res A 86A:1077-1087 (2008).
66. Chan AW, Whitney RA and Neufeld RJ, Semisynthesis of a controlled stimuli-responsive alginate hydrogel. Biomacromolecules 10:609-616 (2009).
67. Yamada Y, Hozumi K, Katagiri F, Kikkawa Y and Nomizu M, Biological activity of laminin peptide-conjugated alginate and chitosan matrices. Biopolymers 94:711-720 (2010).
68. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, et al., Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26:319-326 (2005).
69. Makogonenko E, Tsurupa G, Ingham K and Medved L, Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. Biochemistry - Us 41:7907-7913 (2002).
70. Preissner KT and Jenne D, Vitronectin - a new molecular connection in hemostasis. Thromb Haemostasis 66:189-194 (1991).
71. Sahni A and Francis CW, Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96:3772-3778 (2000).
72. Prasad CK and Krishnan LK, Regulation of endothelial cell phenotype by biomimetic matrix coated on biomaterials for cardiovascular tissue engineering. Acta Biomater 4:182-191 (2008).
73. Mol A, van Lieshout MI, Veen CGD, Neuenschwander S, Hoerstrup SP, Baaijens FPT, et al., Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26:3113-3121 (2005).
74. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, et al., Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardio -Thorac 19:424-430 (2001).
75. Janmey PA, Winer JP and Weisel JW, Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6:1-10 (2009).
76. Le Nihouannen D, Le Guehennec L, Rouillon T, Pilet P, Bilban M, Layrolle P, et al., Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials 27:2716-2722 (2006).
77. Eyrich D, Brandl F, Appel B, Wiese H, Maier G, Wenzel M, et al., Long-term stable fibrin gels for cartilage engineering. Biomaterials 28:55-65 (2007).
78. Bruns H, Kneser U, Holzhuter S, Roth B, Kluth J, Kaufmann PM, et al., Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng 11:1718-1726 (2005).
79. Peura M, Siltanen A, Saarinen I, Soots A, Bizik J, Vuola J, et al., Paracrine factors from fibroblast aggregates in a fibrin-matrix carrier enhance keratinocyte viability and migration. J Biomed Mater Res A 95A:658-664 (2010).
80. Park SH, Park SR, Chung SI, Pai KS and Min BH, Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Artif Organs 29:838-845 (2005).
81. Zhao HG, Ma L, Gao CY and Shen JC, A composite scaffold of PLGA microspheres/fibrin gel for cartilage tissue engineering: fabrication, physical properties, and cell responsiveness. J Biomed Mater Res B 88B:240-249 (2009) (2010).
82. Eyrich D, Wiese H, Mailer G, Skodacek D, Appel B, Sarhan H, et al., In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Eng 13:2207-2218 (2007).
83. Jiang B, Waller TM, Larson JC, Appel AA and Brey EM, Fibrin-loaded porous poly(ethylene glycol) hydrogels as scaffold materials for vascularized tissue formation. Tissue Eng Part A 19:224-234 (2013).
84. Zhao HG, Ma L, Zhou J, Mao ZW, Gao CY and Shen JC, Fabrication and physical and biological properties of fibrin gel derived from human plasma. Biomed Mater 3:015001 (2008).
85. Vavken P, Joshi SM and Murray MM, Fibrin concentration affects ACL fibroblast proliferation and collagen synthesis. Knee 18:42-46 (2011).
86. Cox S, Cole M and Tawil B, Behavior of human dermal fibroblasts in three-dimensional fibrin clots: Dependence on fibrinogen and thrombin concentration. Tissue Eng 10:942-954 (2004).
87. Li JM, Chen W, Wang H, Jin C, Yu XJ, Lu WY, et al., Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. Acta Pharmacol Sin 30:1337-1343 (2009).
88. Khan W, Kapoor M and Kumar N, Covalent attachment of proteins to functionalized polypyrrole-coated metallic surfaces for improved biocompatibility. Acta Biomater 3:541-549 (2007).
89. Wei Q, Li BJ, Yi N, Su BH, Yin ZH, Zhang FL, et al., Improving the blood compatibility of material surfaces via biomolecule-immobilized mussel-inspired coatings. J Biomed Mater Res A 96A:38-45 (2011).
90. Zehr KJ, Use of bovine albumin-glutaraldehyde glue in cardiovascular surgery. Ann Thorac Surg 84:1048-1052 (2007).
91. De Somer F, Delanghe J, Somers P, Debrouwere M and Van Nooten G, Mechanical and chemical characteristics of an autologous glue. J Biomed Mater Res A 86A:1106-1112 (2008).
92. Shen ZY, Li Y, Kohama K, Oneill B and Bi JX, Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres. Pharmacol Res 63:51-58 (2011).
93. Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE and D'Souza MJ, Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappa B encapsulated albumin microspheres. J Microencapsul 26:692-700 (2009).
94. Dror Y, Ziv T, Makarov V, Wolf H, Admon A and Zussman E, Nanofibers made of globular proteins. Biomacromolecules 9:2749-2754 (2008).
95. Regev O, Khalfin R, Zussman E and Cohen Y, About the albumin structure in solution and related electro-spinnability issues. Int J Biol Macromol 47:261-265 (2010).
96. Kosir MA, Quinn CCV, Wang WL and Tromp G, Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing. J Surg Res 92:45-52 (2000).
97. Malavaki C, Mizumoto S, Karamanos N and Sugahara K, Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease. Connect Tissue Res 49:133-139 (2008).
98. van Susante JLC, Pieper J, Buma P, van Kuppevelt TH, van Beuningen H, van der Kraan PM, et al., Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials 22:2359-2369 (2001).
99. Park JS, Yang HJ, Woo DG, Yang HN, Na K and Park KH, Chondrogenic differentiation of mesenchymal stem cells embedded in a scaffold by long-term release of TGF-beta 3 complexed with chondroitin sulfate. J Biomed Mater Res A 92A:806-816 (2010).
100. Chang KY, Hung LH, Chu IM, Ko CS and Lee YD, The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering. J Biomed Mater Res A 92A:712-723 (2010).
101. Villanueva I, Gladem SK, Kessler J and Bryant SJ, Dynamic loading stimulates chondrocyte biosynthesis when encapsulated in charged hydrogels prepared from poly(ethylene glycol) and chondroitin sulfate. Matrix Biol 29:51-62 (2010).
102. Nguyen LH, Kudva AK, Guckert NL, Linse KD and Roy K, Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage. Biomaterials 32:1327-1338 (2011).
103. Liang WH, Kienitz BL, Penick KJ, Welter JF, Zawodzinski TA and Baskaran H, Concentrated collagen-chondroitin sulfate scaffolds for tissue engineering applications. J Biomed Mater Res A 94A:1050-1060 (2010).
104. Shu XZ, Ahmad S, Liu YC and Prestwich GD, Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A 79A:902-912 (2006).
105. Chen YL, Lee HP, Chan HY, Sung LY, Chen HC and Hu YC, Composite chondroitin-6-sulfate/dermatan sulfate/chitosan scaffolds for cartilage tissue engineering. Biomaterials 28:2294-2305 (2007).
106. Van S, Das SK, Wang XH, Feng ZL, Jin Y, Hou Z, et al., Synthesis, characterization, and biological evaluation of poly(L-gamma-glutamyl-glutamine)-paclitaxel nanoconjugate. Int J Nanomed 5:825-837 (2010).
107. Portilla-Arias JA, Camargo B, Garcia-Alvarez M, de Ilarduya AM and Munoz-Guerra S, Nanoparticles made of microbial poly(gamma-glutamate)s for encapsulation and delivery of drugs and proteins. J Biomat Sci - Polym E 20:1065-1079 (2009).
108. Sun Y, Tang YZ, Chu MQ, Song SX and Xin YF, A convenient and adjustable surface-modified complex containing poly-L-glutamic acid conjugates as a vector for gene delivery. Int J Nanomed 3:249-256 (2008).
109. Matsusaki M, Yoshida H and Akashi M, The construction of 3D-engineered tissues composed of cells and extracellular matrices by hydrogel template approach. Biomaterials 28:2729-2737 (2007).
110. Hsu FY, Cheng YY, Tsai SW and Tsai WB, Fabrication and evaluation of a biodegradable cohesive plug based on reconstituted collagen/gamma-polyglutamic acid. J Biomed Mater Res B 95B:29-35 (2010).
111. Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, et al., Chitosan glutamate nanoparticles for protein delivery: development and effect on prolidase stability. J Microencapsul 24:553-564 (2007).
112. Deng C, Tian HY, Zhang PB, Sun J, Chen XS and Jing XB, Synthesis and characterization of RGD peptide grafted poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-glutamic acid) triblock copolymer. Biomacromolecules (2006)7:590-596.
113. Gryparis EC, Mattheolabakis G, Bikiaris D and Avgoustakis K, Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin. Drug Deliv 14:371-380 (2007).
114. Cao N, Cheng D, Zou SY, Ai H, Gao JM and Shuai XT, The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials 32:2222-2232 (2011).
115. Takehara M, Hibino A, Saimura M and Hirohara H, High-yield production of short chain length poly(epsilon-l-lysine) consisting of 5-20 residues by Streptomyces aureofaciens, and its antimicrobial activity. Biotechnol Lett 32:1299-1303 (2010).
116. Tang CK, Sheng KC, Pouniotis D, Esparon S, Son HY, Kim CW, et al., Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses. Vaccine (2008)26:3827-3834.
117. Isaksson K, Akerberg D, Andersson R and Tingstedt B, Toxicity and dose response of intra-abdominally administered poly-L-alpha-lysine and poly-L-glutamate for postoperative adhesion protection. Eur Surg Res 44:17-22 (2010).
118. Bertram JP, Jay SM, Hynes SR, Robinson R, Criscione JM and Lavik EB, Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility. Acta Biomater 5:2860-2871 (2009).
119. Tahara K, Furukawa S, Yamamoto H and Kawashima Y, Hybrid-modified poly(D, L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system. Int J Pharm 392:311-313 (2010).
120. Nottelet B, El Ghzaoui A, Coudane J and Vert M, Novel amphiphilic poly(epsilon-caprolactone)-g-poly(L-lysine) degradable copolymers. Biomacromolecules 8:2594-2601 (2007).
121. Chu CFL, Lu A, Liszkowski M and Sipehia R, Enhanced growth of animal and human endothelial cells on biodegradable polymers. Bba - Gen Subjects 1472:479-485 (1999).
122. Zhang R and Ma PX, Processing of polymer scaffolds: phase separation, in Methods of Tissue Engineering, ed by Atala A LR. Academic Press: San Diego; 715 (2001).
123. Pachence JM KJ, Biodegradable polymers, in: Principles of Tissue Engineering, 2nd edn, ed by Lanza RP LR, Chick WL. Academic Press: San Diego; 263 (2000).
124. Bolland BJRF, Kanczler JM, Ginty PJ, Howdle SM, Shakesheff KM, Dunlop DG, et al. The application of human bone marrow stromal cells and poly(DL-lactic acid) as a biological bone graft extender in impaction bone grafting. Biomaterials 29:3221-3227 (2008).
125. Eschbach L, Nonresorbable polymers in bone surgery. Injury 31:S22-S7 (2000).
126. Kurtz SM and Devine JN, PEEK biomaterials in trauma, orthopedic, and spinal implants. Biomaterials 28:4845-4869 (2007).
127. von Wilmowsky C, Vairaktaris E, Pohle D, Rechtenwald T, Lutz R, Munstedt H, et al., Effects of bioactive glass and beta-TCP containing three-dimensional laser sintered polyetheretherketone composites on osteoblasts in vitro. J Biomed Mater Res A 87A:896-902 (2008).
128. Sagomonyants KB, Jarman-Smith ML, Devine JN, Aronow MS and Gronowicz GA, The in vitro response of human osteoblasts to polyetheretherketone (PEEK) substrates compared to commercially pure titanium. Biomaterials 29:1563-1572 (2008).
129. Morrison C, Macnair R, Macdonald C, Wykman A, Goldie I and Grant MH, In vitro biocompatibility testing of polymers for orthopedic implants using cultured fibroblasts and osteoblasts. Biomaterials 16:987-992 (1995).
130. Scotchford CA, Garle MJ, Batchelor J, Bradley J and Grant DM, Use of a novel carbon fibre composite material for the femoral stem component of a THR system: in vitro biological assessment. Biomaterials24:4871-4879 (2003).
131. Katzer A, Marquardt H, Westendorf J, Wening JV and von Foerster G, Polyetheretherketone - cytotoxicity and mutagenicity in vitro. Biomaterials 23:1749-1759 (2002).
132. von Wilmowsky C, Lutz R, Meisel U, Srour S, Rupprecht S, Toyoshima T, et al., In vivo evaluation of beta-TCP containing 3D laser sintered poly(ether ether ketone) composites in pigs. J Bioact Compat Pol 24:169-184 (2009).
133. Nieminen T, Kallela I, Wuolijoki E, Kainulainen H, Hiidenheimo I and Rantala I, Amorphous and crystalline polyetheretherketone: mechanical properties and tissue reactions during a 3-year follow-up. J Biomed Mater Res A 84A:377-383 (2008).
134. Jockisch KA, Brown SA, Bauer TW and Merritt K, Biological response to chopped-carbon-fiber-reinforced peek. J Biomed Mater Res 26:133-146 (1992).
135. Scholes SC and Unsworth A, Pitch-based carbon-fibre-reinforced poly (ether-ether-ketone) OPTIMA (R) assessed as a bearing material in a mobile bearing unicondylar knee joint. P I Mech Eng H 223:13-25 (2009).
136. Toth JM, Wang M, Estes BT, Scifert JL, Seim HB and Turner AS, Polyetheretherketone as a biomaterial for spinal applications. Biomaterials 27:324-334 (2006).
137. Scolozzi P, Martinez A and Jaques B, Complex orbito-fronto-temporal reconstruction using computer-designed PEEK implant. J Craniofac Surg 18:224-228 (2007).
138. Zhao Y, Wong HM, Wang W, Li P, Xu Z, Chong EY, et al., Cytocompatibility, osseointegration, and bioactivity of three-dimensional porous and nanostructured network on polyetheretherketone. Biomaterials 34:9264-9277 (2013).
139. Edwards SL and Werkmeister JA, Mechanical evaluation and cell response of woven polyetheretherketone scaffolds. J Biomed Mater Res A 100:3326-3331 (2012).
140. Roeder RK and Conrad TL, Bioactive polyaryletherketone composites, in PEEK Biomaterials Handbook, ed by Kurtz SM. William Andrew: Oxford, UK; 163-79 (2012).
141. Converse GL, Conrad TL, Merrill CH and Roeder RK, Hydroxyapatite whisker-reinforced polyetherketoneketone bone ingrowth scaffolds. Acta Biomater 6:856-863 (2012).
142. Yu SC, Hariram KP, Kumar R, Cheang P and Aik KK, In vitro apatite formation and its growth kinetics on hydroxyapatite/polyetheretherketone biocomposites. Biomaterials 26:2343-2452 (2005).
143. Wong KL, Wong CT, Liu WC, Pan HB, Fong MK, Lam WM, et al., Mechanical properties and in vitro response of strontium-containing hydroxyapatite/polyetheretherketone composites. Biomaterials 30:3810-3817 (2009).
144. Fujihara K, Huang ZM, Ramakrishna S, Satknanantham K and Hamada H, Performance study of braided carbon/PEEK composite compression bone plates. Biomaterials 24:2661-2667 (2003).
145. Fujihara K, Huang ZM, Ramakrishna S, Satknanantham K and Hamada H, Feasibility of knitted carbon/PEEK composites for orthopedic bone plates. Biomaterials 25:3877-3885 (2004).
146. Karageorgiou V and Kaplan D, Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26:5474-5491 (2005).
147. Chu PP, Wu CS, Liu PC, Wang TH and Pan JP, Proton exchange membrane bearing entangled structure: sulfonated poly (ether ether ketone)/bismaleimide hyperbranch. Polymer 51:1386-1394 (2010).
148. Ryan G, Pandit A and Apatsidis DP, Fabrication methods of porous metals for use in orthopaedic applications. Biomaterials 27:2651-2670 (2006).
149. Mohanna PN, Young RC, Wiberg M and Terenghi G, A composite poly-hydroxybutyrate-glial growth factor conduit for long nerve gap repairs. J Anat 203:553-565 (2003).
150. Misra SK, Valappil SP, Roy I and Boccaccini AR, Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules 7:2249-2258 (2006).
151. Reusch RN, Sparrow AW and Gardiner J, Transport of poly-beta-hydroxybutyrate in human plasma. Biochim Biophys Acta 1123:3340 (1992).
152. Bergstrand A, Uppstrom S and Larsson A, Permeability of porous poly(3-hydroxybutyrate) barriers of single and bilayer type for implant applications. Int J Polym Sci (2014).
153. Masaeli E, Morshed M, Rasekhian P, Karbasi S, Karbalaie K, Karamali F, Abedi D, Razavi S, Jafarian-Dehkordi A, Nasr-Esfahani MH and Baharvand H, Does the tissue engineering architecture of poly(3-hydroxybutyrate) scaffold affects cell-material interactions? J Biomed Mater Res A 100A:1907-1918 (2012).
154. Cai ZJ, Biocompatibility and biodegradation of novel PHB porous substrates with controlled multi-pore size by emulsion templates method. J Mater Sci - Mater M 17:1297-1303 (2006).
155. Karahaliloglu Z, Demirbilek M, Sam M, Erol-Demirbilek M, Saglam N and Denkbas EB, Plasma polymerization-modified bacterial polyhydroxybutyrate nanofibrillar scaffolds. J Appl Polym Sci 128:19041912 (2013).
156. Seal BL, Otero TC and Panitch A, Polymeric biomaterials for tissue and organ regeneration. Mat Sci Eng R 34:147-230 (2001).
157. Maurus PB and Kaeding CC, Bioabsorbable implant material review. Oper Techn Sport Med 12:158-160 (2004).
158. Ma PX and Langer R, Degradation, structure and properties of fibrous nonwoven poly(glycolic acid) scaffolds for tissue engineering. Mater Res Soc Symp P 394:99-104 (1995).
159. Reed AM and Gilding DK, Biodegradable polymers for use in surgery - poly(glycolic)-poly(lactic acid) homo and co-polymers .2. Invitro degradation. Polymer 22:494-498 (1981).
160. Gilding DK and Reed AM, Biodegradable polymers for use in surgery - polyglycolic-poly(actic acid) homopolymers and copolymers. P olymer 20:1459-1464 (1979).
161. Aydin HM, A three-layered osteochondral plug: structural, mechanical, and in vitro compatibility analysis. Adv Eng Mater 13:B511-B517 (2011).
162. Otto J, Binnebosel M, Pietsch S, Anurov M, Titkova S, Ottinger AP, et al., Large-pore PDS mesh compared to small-pore PG mesh. J Invest Surg 23:190-196 (2010).
163. Ceonzo K, Gaynor A, Shaffer L, Kojima K, Vacanti CA and Stahl GL, Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation. Tissue Eng 12:301-308 (2006).
164. Zhang RY and Ma PX, Degradation behavior of porous poly(alpha-hydroxy acids)/hydroxyapatite composite scaffolds. Abstr Papers Am Chem S 220:U251 (2000).
165. Eling B, Gogolewski S and Pennings AJ, Biodegradable materials of poly(L-lactic acid) .1. Melt-spun and solution-spun fibers. Polymer 23:1587-1593 (1982).
166. Aydin HM, El Haj AJ, Pişkin E, Yang Y, Improving pore interconnectivity in polymeric scaffolds for tissue engineering. J Tiss Eng Reg Med 3:470-476 (2009).
167. Aydin HM and Yang Y, Rapid production of highly interconnedted porous scaffolds by spheroidized sugar particles for tissue engineering. Journal of Hacettepe Biology and Chemistry 39:23-28 (2011).
168. Anderson KS, Schreck KM and Hillmyer MA, Toughening polylactide. Polym Rev 48:85-108 (2008).
169. Ueda H and Tabata Y, Polyhydroxyalkanonate derivatives in current clinical applications and trials. Adv Drug Deliver Rev 55:501-518 (2003).
170. Thomas C, Gupta V and Ahsan F, Particle Size influences the immune response produced by Hepatitis B vaccine formulated in inhalable particles. Pharm Res - Dordr 27:905-919 (2010).
171. Zolnik BS and Burgess DJ, Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 127:137-145 (2008).
172. Gavenis K, Schneider U, Groll J and Schmidt-Rohlfing B, BMP-7-loaded PGLA microspheres as a new delivery system for the cultivation of human chondrocytes in a collagen type I gel: the common nude mouse model. Int J Artif Organs 33:45-53 (2010).
173. Ye ML, Kim S and Park K, Issues in long-term protein delivery using biodegradable microparticles. J Control Release 146:241-260 (2010).
174. Berkland C, Pollauf E, Varde N, Pack DW and Kim K, Monodisperse liquid-filled biodegradable microcapsules. Pharm Res - Dordr 24:1007-1013 (2007).
175. Haddadi A, Aboofazeli R, Erfan M and Farboud ES, Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams. J Microencapsul 25:379-386 (2008).
176. Vega E, Gamisans F, Garcia ML, Chauvet A, Lacoulonche F and Egea MA, PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci - Us 97:5306-5317 (2008).
177. Xie JW and Wang CH, Electrospun micro- and nano-fibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res - Dordr 23:1817-1826 (2006).
178. Ionescu LC, Lee GC, Sennett BJ, Burdick JA and Mauck RL, An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering. Biomaterials 31:4113-4120 (2010).
179. Miller RA, Brady JM and Cutright DE, Degradation rates of oral resorbable implants (polylactates and polyglycolates) - rate modification with changes in Pla-Pga copolymer ratios. J Biomed Mater Res 11:711-719 (1977).
180. Freed LE, Vunjaknovakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, et al., Biodegradable polymer scaffolds for tissue engineering. Bio - Technol 12:689-693 (1994).
181. Patrick JC MA and Mclntire VL, Frontiers in Tissue Engineering. Pergamon: New York (1998).
182. Patlolla A, Collins G and Arinzeh TL, Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration. Acta Biomater 6:90-101 (2010).
183. Lam CXF, Hutmacher DW, Schantz JT, Woodruff MA and Teoh SH, Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A 90A:906-919 (2009).
184. Woodruff MA and Hutmacher DW, The return of a forgotten polymer - Polycaprolactone in the 21st century. Prog Polym Sci 35:1217-1256 (2010).
185. 2 for bone tissue engineering. J Bioact Compat Pol 19:383-394 (2004).
186. Dash TK and Konkimalla VB, Poly-epsilon-caprolactone based formulations for drug delivery and tissue engineering: a review. J Control Release 158:15-33 (2012).
187. Aydin HM, Korkusuz P, Vargel I, Kilic E, Guzel E, Cavusoglu T, Ucgan D and Piskin E, A 6-month in vivo study of polymer/mesenchymal stem cell constructs for cranial defects. J Bioact Compat Pol 26:207-221 (2011).
188. Aydin HM, Turk M, Calimli A and Pişkin E, Attachment and growth of fibroblasts on poly(L-lactide/epsilon-caprolactone) scaffolds prepared in supercritical CO2 and modified by polyethylene imine grafting with ethylene diamine-plasma in a glow-discharge apparatus. Int J Artif Organs 29:873-880 (2006).
189. Li WJ, Danielson KG, Alexander PG and Tuan RS, Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A 67A:1105-1114 (2003).
190. Hutmacher DW, Scaffolds in tissue engineering bone and cartilage. Biomaterials 21:2529-2543 (2000).
191. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, et al., A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26:599-609 (2005).
192. CG. P. Poly-epsilon-caprolactone and its copolymers, in Biodegradable Polymers as Drug Delivery Systems, ed by Chasin M LR. Marcel Dekker: New York; 71-120 (1990).
193. Gan ZH, Yu DH, Zhong ZY, Liang QZ and Jing XB, Enzymatic degradation of poly(epsilon-caprolactone)/poly(DL-lactide) blends in phosphate buffer solution. Polymer 40:2859-2862 (1999).
194. Assoian RK, Komoriya A, Meyers CA, Miller DM and Sporn MB, Transforming growth factor-beta in human-platelets - identification of a major storage site, purification, and characterization. J Biol Chem 258:7155-7160 (1983).
195. Joyce ME, Roberts AB, Sporn MB and Bolander ME, Transforming growth-factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110:2195-2207 (1990).
196. Ye WP, Du FS, Jin JY, Yang JY and Xu Y, In vitro degradation of poly(caprolactone), poly(lactide) and their block copolymers: influence of composition, temperature and morphology. React Funct Polym 32:161-168 (1997).
197. Guelcher SA, Biodegradable polyurethanes: synthesis and applications in regenerative medicine. Tissue Eng Pt B - Rev 14:3-17 (2008).
198. Guan JJ, Fujimoto KL, Sacks MS and Wagner WR, Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials 26:3961-3971 (2005).
199. Shi R, Chen DF, Liu QY, Wu Y, Xu XC, Zhang LQ, et al., Recent advances in synthetic bioelastomers. Int J Mol Sci 10:4223-4256 (2009).
200. Bonzani IC, Adhikari R, Houshyar S, Mayadunne R, Gunatillake P and Stevens MM, Synthesis of two-component injectable polyurethanes for bone tissue engineering. Biomaterials 28:423-433 (2007).
201. Fisher JP, Vehof JWM, Dean D, van der Waerden JPCM, Holland TA, Mikos AG, et al., Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res 59:547-556 (2002).
202. Hedberg EL, Kroese-Deutman HC, Shih CK, Crowther RS, Carney DH, Mikos AG, et al., Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. J Biomed Mater Res A 72A:343-353 (2005).
203. He S, Timmer MD, Yaszemski MJ, Yasko AW, Engel PS and Mikos AG, Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)-diacrylate macromers as crosslinking agents and characterization of their degradation products. Polymer 42:1251-1260 (2001).
204. Christenson EM, Soofi W, Holm JL, Cameron NR and Mikos AG, Biodegradable fumarate-based polyHIPEs as tissue engineering scaffolds. Biomacromolecules 8:3806-3814 (2007).
205. Kim CW, Talac R, Lu LC, Moore MJ, Currier BL and Yaszemski MJ, Characterization of porous injectable poly-(propylene fumarate)-based bone graft substitute. J Biomed Mater Res A 85A:1114-1119 (2008).
206. Young S, Patel ZS, Kretlow JD, Murphy MB, Mountziaris PM, Baggett LS, et al., Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Pt A (2009)15:2347-2362.
207. Vehof JWM, Fisher JP, Dean D, van der Waerden JPCM, Spauwen PHM, Mikos AG, et al., Bone formation in transforming growth factor beta-1-coated porous poly(propylene fumarate) scaffolds. J Biomed Mater Res 60:241-251 (2002).
208. Lee KW, Wang SF, Fox BC, Ritman EL, Yaszemski MJ and Lu LC, Poly(propylene fumarate) bone tissue engineering scaffold fabrication using stereolithography: effects of resin formulations and laser parameters. Biomacromolecules 8:1077-1084 (2007).
209. Lee J, Kim B, Lim G and Cho DW, Scaffold fabrication with biodegradable poly(propyllene fumarate) using microstereolithography. Key Eng Mater 342-343:141-144 (2007).
210. Wolfe MS, Dean D, Chen JE, Fisher JP, Han SH, Rimnac CM, et al. In vitro degradation and fracture toughness of multilayered porous poly(propylene fumarate)/beta-tricalcium phosphate scaffolds. J Biomed Mater Res 61:159-164 (2002).
211. Kharas GB, Kamenetsky M, Simantirakis J, Beinlich KC, Rizzo AMT, Caywood GA, et al., Synthesis and characterization of fumarate-based polyesters for use in bioresorbable bone cement composites. J Appl Polym Sci 66:1123-1137 (1997).
212. Hedberg EL, Temenoff JS, Tang A, Crowther RS, Carney DH and Mikos AG, Controlled release of a tissue inducing peptide from oligo(poly(ethylene glycol) fumarate) hydrogels for orthopedic tissue engineering. 24th Annual Conference and the Annual Fall Meeting of the Biomedical Engineering Society EMBS/BMES Conference, 2002. IEEE; 1:472-473 (2002).
213. Wang SF, Kempen DH, Simha NX, Lewis JL, Windebank AJ, Yaszemski MJ, et al., Photo-cross-linked hybrid polymer networks consisting of poly(propylene fumarate) and poly(caprolactone fumarate): controlled physical properties and regulated bone and nerve cell responses. Biomacromolecules 9:1229-1241 (2008).
214. Payne RG, McGonigle JS, Yaszemski MJ, Yasko AW and Mikos AG, Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 2. Viability of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 23:4373-4380 (2002).
215. Nam YS and Park TG, Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res 47:8-17 (1999).
216. Lewandrowski KU, Cattaneo MV, Gresser JD, Wise DL, White RL, Bonassar L, et al. Effect of a poly(propylene fumarate) foaming cement on the healing of bone defects. Tissue Eng 5:305-316 (1999).
217. Peter SJ, Miller ST, Zhu GM, Yasko AW and Mikos AG, In vivo degradation of a poly(propylene fumarate) beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res 41:1-7 (1998).
218. Hedberg EL, Kroese-Deutman HC, Shih CK, Crowther RS, Carney DH, Mikos AG, et al., In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds. Biomaterials 26:4616-4623 (2005).
219. Lukashev M, Zeng W, Goelz S, Lee D, Linker R, Gold R, et al., Activation of Nrf2 and modulation of disease progression in EAE models by BG00012 (dimethyl fumarate) suggests a novel mechanism of action combining anti-inflammatory and neuroprotective modalities. Mult Scler 13:S149 (2007).
220. Lee KW, Wang S, Yaszemski MJ and Lu LC, Physical properties and cellular responses to crosslinkable poly(propylene fumarate)/hydroxyapatite nanocomposites. Biomaterials 29:2839-2848 (2008).
221. Bourke SL and Kohn J, Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv Drug Deliver Rev 55:447-466 (2003).
222. Yuan H, Luo K, Lai YS, Pu YJ, He B, Wang G, et al., A novel poly(L-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions. Mol Pharmaceut 7:953-962 (2010).
223. Wadhwa S and Mumper RJ, Intracellular delivery of the reactive oxygen species generating agent D-penicillamine upon conjugation to poly-L-glutamic acid. Mol Pharmaceut 7:854-862 (2010).
224. Chiu HC, Kopeckova P, Deshmane SS and Kopecek J, Lysosomal degradability of poly(alpha-amino acids). J Biomed Mater Res 34:381-392 (1997).
225. Feng XL, Lv FT, Liu LB, Tang HW, Xing CF, Yang QO, et al. Conjugated polymer nanoparticles for drug delivery and imaging. Acs Appl Mater Inter 2:2429-2435 (2010).
226. Ke TY, Feng Y, Guo JY, Parker DL and Lu ZR, Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging. Magn Reson Imaging 24:931-940 (2006).
227. Kakizawa Y, Furukawa S and Kataoka K, Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. J Control Release 97:345-356 (2004).
228. Karal-Yilmaz O, Kayaman-Apohan N, Misirli Z, Baysal K and Baysal BM, Synthesis and characterization of poly(L-lactic acid-co-ethylene oxide-co-aspartic acid) and its interaction with cells. J Mater Sci - Mater Med 17:213-227 (2006).
229. Cha EJ, Kim JE and Ahn CH, Stabilized polymeric micelles by electrostatic interactions for drug delivery system. Eur J Pharm Sci 38:341-346 (2009).
230. Ng SY, Vandamme T, Taylor MS and Heller J, Synthesis and erosion studies of self-catalyzed poly(ortho ester)s. Macromolecules 30:770-772 (1997).
231. Heller J, Barr J, Ng SY, Abdellauoi KS and Gurny R, Poly(ortho esters): synthesis, characterization, properties and uses. Adv Drug Deliver Rev 54:1015-1039 (2002).
232. Heller J and Barr J, Poly(ortho esters) - from concept to reality. Biomacromolecules 5:1625-1632 (2004).
233. Kipper MJ, Wilson JH, Wannemuehler MJ and Narasimhan B, Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J Biomed Mater Res A 76A:798-810 (2006).
234. Carrillo-Conde B, Schiltz E, Yu J, Minion FC, Phillips GJ, Wannemuehler MJ, et al., Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens. Acta Biomater 6:3110-3119 (2010).
235. Sun L, Zhou SB, Wang WJ, Su QX, Li XH and Weng J, Preparation and characterization of protein-loaded polyanhydride microspheres. J Mater Sci - Mater M 20:2035-2042 (2009).
236. Salman HH, Irache JM and Gamazo C, Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccine 27:4784-4790 (2009).
237. Tamayo I, Irache JM, Mansilla C, Ochoa-Reparaz J, Lasarte JJ and Gamazo C, Poly(anhydride) nanoparticles act as active Th1 adjuvants through toll-Like receptor exploitation. Clin Vaccine Immunol 17:1356-1362 (2010).
238. Petersen LK, Sackett CK and Narasimhan B, High-throughput analysis of protein stability in polyanhydride nanoparticles. Acta Biomater 6:3873-3881 (2010).
239. Ibim SEM, Uhrich KE, Attawia M, Shastri VR, El-Amin SF, Bronson R, et al., Preliminary in vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial model. J Biomed Mater Res 43:374-379 (1998).
240. Weiner AA, Shuck DM, Bush JR and Shastri VP, In vitro degradation characteristics of photocrosslinked anhydride systems for bone augmentation applications. Biomaterials 28:5259-5270 (2007).
241. Determan AS, Trewyn BG, Lin VSY, Nilsen-Hamilton M and Narasimhan B, Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. J Control Release 100:97-109 (2004).
242. Weiner AA, Bock EA, Gipson ME and Shastri VP, Photocrosslinked anhydride systems for long-term protein release. Biomaterials 29:2400-2407 (2008).
243. Attawia MA, Uhrich KE, Botchwey E, Fan M, Langer R and Laurencin CT, Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications. J Biomed Mater Res 29:1233-1240 (1995).
244. Uhrich KE, Gupta A, Thomas TT, Laurencin CT and Langer R, Synthesis and characterization of degradable poly(anhydride-co-imides). Macromolecules 28:2184-2193 (1995).
245. Wang YD, Ameer GA, Sheppard BJ and Langer R, A tough biodegradable elastomer. Nat Biotechnol 20:602-606 (2002).
246. Vert M, Li SM, Spenlehauer G and Guerin P, Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci - Mater M 3:432-446 (1992).
247. Aydin HM, Kourush S, Rzayev Z, Piskin E, Microwave-assisted Rapid Synthesis of Poly(glycerol-sebacate) Elastomers. Biomat Sci 1:503-509 (2013).
248. Aydin HM, Kourush S, Yilmaz M, Turk M, Rzayev Z, Piskin E, The Catalyst Assisted Two Stage Synthesis of Poly(glycerol-co-sebacate-co-e-caprolactone) Elastomers As Potential Tissue Engineering Materials. J Tiss Eng Reg DOI: 10.1002/term.1759 (2012).
249. Kemppainen JM and Hollister SJ, Tailoring the mechanical properties of 3D-designed poly(glycerol sebacate) scaffolds for cartilage applications. J Biomed Mater Res A 94A:9-18 (2010).
250. Chen QZ, Bismarck A, Hansen U, Junaid S, Tran MQ, Harding SE, et al., Characterisation of a soft elastomer poly(glycerol sebacate) designed to match the mechanical properties of myocardial tissue. Biomaterials 29:47-57 (2008).
251. Liu QY, Tian M, Shi R, Zhang LQ, Chen DF and Tian W, Structure and properties of thermoplastic poly(glycerol sebacate) elastomers originating from prepolymers with different molecular weights. J Appl Polym Sci 104:1131-1137 (2007).
252. Ifkovits JL, Padera RF and Burdick JA, Biodegradable and radically polymerized elastomers with enhanced processing capabilities. Biomed Mater 3:034104 (2008).
253. Cai W and Liu LL, Shape-memory effect of poly (glycerol-sebacate) elastomer. Mater Lett 62:2171-2173 (2008).
254. Jaafar IH, Ammar MM, Jedlicka SS, Pearson RA and Coulter JP, Spectroscopic evaluation, thermal, and thermomechanical characterization of poly(glycerol-sebacate) with variations in curing temperatures and durations. J Mater Sci 45:2525-2529 (2010).
255. Komatsu K and Chiba M, The effect of velocity of loading on the biomechanical responses of the periodontal-ligament in transverse sections of the rat molar in vitro. Arch Oral Biol 38:369-375 (1993).
256. Sundback CA, Shyu JY, Wang YD, Faquin WC, Langer RS, Vacanti JP, et al., Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials 26:5454-5464 (2005).
257. Crapo PM and Wang YD, Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials 31:1626-1635 (2010).
258. Gao J, Ensley AE, Nerem RM and Wang YD, Poly(glycerol sebacate) supports the proliferation and phenotypic protein expression of primary baboon vascular cells. J Biomed Mater Res A 83A:1070-1075 (2007).
259. Chen QZ, Jin LY, Cook WD, Mohn D, Lagerqvist EL, Elliott DA, et al., Elastomeric nanocomposites as cell delivery vehicles and cardiac support devices. Soft Matter. 6:4715-4726 (2010).
260. Sales VL, Engelmayr GC, Johnson JA, Gao J, Wang YD, Sacks MS, et al., Protein precoating of elastomeric tissue-engineering scaffolds increased cellularity, enhanced extracellular matrix protein production, and differentially regulated the phenotypes of circulating endothelial progenitor cells. Circulation 116:I55-I63 (2007).
261. Chen QZ, Liang SL, Wang J and Simon GP, Manipulation of mechanical compliance of elastomeric PGS by incorporation of halloysite nanotubes for soft tissue engineering applications. J Mech Behav Biomed 4:1805-1818 (2011).
262. Sant S, Hwang CM, Lee SH and Khademhosseini A, Hybrid PGS-PCL microfibrous scaffolds with improved mechanical and biological properties. J Tissue Eng Regen M 5:283-291 (2011).
263. Laurencin CT, Koh HJ, Neenan TX, Allcock HR and Langer R, Controlled release using a new bioerodible polyphosphazene matrix system. J Biomed Mater Res 21:1231-1246 (1987).
264. Qiu LY and Zhu KJ, Novel biodegradable polyphosphazenes containing glycine ethyl ester and benzyl ester of amino acethydroxamic acid as cosubstituents: syntheses, characterization, and degradation properties. J Appl Polym Sci 77:2987-2995 (2000).
265. Behravesh E, Yasko AW, Engel PS and Mikos AG, Synthetic biodegradable polymers for orthopaedic applications. Clin Orthop Relat R 367:S118-S129 (1999).
266. Allcock HR, Inorganic-organic polymers as a route to biodegradable materials. Macromol Symp 144:33-46 (1999).
267. Lakshmi S, Katti DS and Laurencin CT, Biodegradable polyphosphazenes for drug delivery applications. Adv Drug Deliver Rev 55:467-482 (2003).
268. Weikel AL, Owens SG, Morozowich NL, Deng M, Nair LS, Laurencin CT, et al., Miscibility of choline-substituted polyphosphazenes with PLGA and osteoblast activity on resulting blends. Biomaterials 31:8507-8515 (2010).
269. Singh A, Krogman NR, Sethuraman S, Nair LS, Sturgeon JL, Brown PW, et al., Effect of side group chemistry on the properties of biodegradable L-alanine cosubstituted polyphosphazenes. Biomacromolecules. 7:914-918 (2006).
270. Verret V, Wassef M, Pelage JP, Ghegediban SH, Jouneau L, Moine L, et al., Influence of degradation on inflammatory profile of polyphosphazene coated PMMA and trisacryl gelatin microspheres in a sheep uterine artery embolization model. Biomaterials 32:339-351 (2011).
271. Stampfl U, Sommer CM, Thierjung H, Stampfl S, Lopez-Benitez R, Radeleff B, et al. Reduction of Late In-Stent Stenosis in a Porcine Coronary Artery Model by Cobalt Chromium Stents with a Nanocoat of Polyphosphazene (Polyzene-F). Cardiovasc Inter Rad 31:1184-1192 (2008).
272. Conconi MT, Lora S, Baiguera S, Boscolo E, Folin M, Scienza R, et al., In vitro culture of rat neuromicrovascular endothelial cells on polymeric scaffolds. J Biomed Mater Res A 71A:669-674 (2004).
273. Zhang QS, Yan YH, Li SP and Feng T, The synthesis and characterization of a novel biodegradable and electroactive polyphosphazene for nerve regeneration. Mat Sci Eng C - Mater 30:160-166 (2010).
274. Deng M, Nair LS, Nukavarapu SP, Kumbar SG, Jiang T, Krogman NR, et al., Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid). Biomaterials 29:337-349 (2008).
275. Nair LS, Bhattacharyya S, Bender JD, Greish YE, Brown PW, Allcock HR, et al., Fabrication and optimization of methylphenoxy substituted polyphosphazene nanofibers for biomedical applications. Biomacromolecules 5:2212-2220 (2004).
276. Potta T, Chun C and Song SC, Chemically crosslinkable thermosensitive polyphosphazene gels as injectable materials for biomedical applications. Biomaterials 30:6178-6192 (2009).
277. Park MR, Chun CJ, Ahn SW, Ki MH, Cho CS and Song SC, Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel. J Control Release 147:359-367 (2010).
278. Qiu ZC, Zhang JJ, Zhou Y, Song BY, Chang JJ, Yang KK, et al., Biodegradable poly(p-dioxanone) reinforced and toughened by organo-modified vermiculite. Polym Advan Technol 22:993-1000 (2011).
279. Malnati GA and Stone EA, Clinical-experience with polydioxanone suture material. Vet Surg 12:24-25 (1983).
280. Elisseeff J, McIntosh W, Anseth K, Riley S, Ragan P and Langer R, Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res 51:164-171 (2000).
281. Alcantar NA, Aydil ES and Israelachvili JN, Polyethylene glycol-coated biocompatible surfaces. J Biomed Mater Res 51:343-351 (2000).
282. Gombotz WR, Guanghui W, Horbett TA and Hoffman AS, Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res 25:1547-1562 (1991).
283. Ostuni E, Chapman RG, Holmlin RE, Takayama S and Whitesides GM, A survey of structure-property relationships of surfaces that resist the adsorption of protein. Langmuir 17:5605-5620 (2001).
284. Zhu JM, Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 31:4639-4656 (2010).
285. Burdick JA and Anseth KS, Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 23:4315-4323 (2002).
286. Papadopoulos A, Bichara DA, Zhao X, Ibusuki S, Randolph MA, Anseth KS, et al., Injectable and photopolymerizable tissue-engineered auricular cartilage using poly(ethylene glycol) dimethacrylate copolymer hydrogels. Tissue Eng Pt A 17:161-169 (2011).
287. Elisseeff J, Anseth K, Sims D, McIntosh W, Randolph M, Yaremchuk M, et al., Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast Reconstr Surg 104:1014-1022 (1999).
288. Burdick JA, Mason MN, Hinman AD, Thorne K and Anseth KS, Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. J Control Release 83:53-63 (2002).
289. Elisseeff J, McIntosh W, Fu K, Blunk T and Langer R, Controlled-release of IGF-I and TGF-beta 1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthopaed Res 19:1098-1104 (2001).
290. Williams CG, Kim TK, Taboas A, Malik A, Manson P and Elisseeff J, In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng 9:679-688 (2003).
291. Cruise GM, Hegre OD, Scharp DS and Hubbell JA, A sensitivity study of the key parameters in the interfacial photopolymerization of poly(ethylene glycol) diacrylate upon porcine islets. Biotechnol Bioeng 57:655-665 (1998).
292. Yang F, Williams CG, Wang DA, Lee H, Manson PN and Elisseeff J, The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials 26:5991-5998 (2005).
293. Varghese S, Hwang NS, Canver AC, Theprungsirikul P, Lin DW and Elisseeff J, Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biol 27:12-21 (2008).
294. Sharma B, Williams CG, Khan M, Manson P and Elisseeff JH, In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel. Plast Reconstr Surg 119:112-120 (2007).
295. Hwang NS, Varghese S, Theprungsirikul P, Canver A and Elisseeff J, Enhanced chondrogenic differentiation of murine embryonic stem cells in hydrogels with glucosamine. Biomaterials 27:6015-6023 (2006).
296. Shin H, Jo S and Mikos AG, Biomimetic materials for tissue engineering. Biomaterials 24:4353-4364 (2003).
297. Lepoittevin B, Devalckenaere M, Pantoustier N, Alexandre M, Kubies D, Calberg C, et al., Poly(epsilon-caprolactone)/clay nanocomposites prepared by melt intercalation: mechanical, thermal and rheological properties. Polymer 43:4017-4023 (2002).
298. Koegler WS and Griffith LG, Osteoblast response to PLGA tissue engineering scaffolds with PEO modified surface chemistries and demonstration of patterned cell response. Biomaterials 25:2819-2830 (2004).
299. Li G, Gill TJ, DeFrate LE, Zayontz S, Glatt V and Zarins B, Biomechanical consequences of PCL deficiency in the knee under simulated muscle loads - an in vitro experimental study. J Orthopaed Res 20:887-892 (2002).
300. Kang XH, Xie YB, Powell HM, Lee LJ, Belury MA, Lannutti JJ, et al., Adipogenesis of murine embryonic stem cells in a three-dimensional culture system using electrospun polymer scaffolds. Biomaterials 28:450-458 (2007).
301. Griffith LG, Polymeric biomaterials. Acta Mater 48:263-277 (2000).
302. Shi XF, Hudson JL, Spicer PP, Tour JM, Krishnamoorti R and Mikos AG, Rheological behaviour and mechanical characterization of injectable poly(propylene fumarate)/single-walled carbon nanotube composites for bone tissue engineering. Nanotechnology 16:S531-S538 (2005).
303. Sitharaman B, Shi XF, Tran LA, Spicer PP, Rusakova I, Wilson LJ, et al., Injectable in situ cross-linkable nanocomposites of biodegradable polymers and carbon nanostructures for bone tissue engineering. J Biomat Sci-Polym E 18:655-671 (2007).
304. Temenoff JS and Mikos AG, Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 21:2405-2412 (2000).
305. Gopferich A and Tessmar J, Polyanhydride degradation and erosion. Adv Drug Deliver Rev 54:911-931 (2002).
306. Zhang Q, Su K, Chan-Park MB, Wu H, Wang D and Xu R, Development of high refractive ZnS/PVP/PDMAA hydrogel nanocomposites for artificial cornea implants. Acta Biomater 10:1167-1176 (2014).
307. Tran RT, Choy WM, Cao H, Qattan I, Chiao JC, Ip WY, et al., Fabrication and characterization of biomimetic multichanneled crosslinked-urethane-doped polyester tissue engineered nerve guides. J Biomed Mater Res A 102:2793-2804 (2014).
308. Sharma B, Fermanian S, Gibson M, Unterman S, Herzka DA, Cascio B, et al., Human cartilage repair with a photoreactive adhesive-hydrogel composite. Sci Translational Med 5:167ra6 (2013).
309. Malafaya PB, Silva GA and Reis RL, Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliver Rev 59:207-233 (2007).
310. Lee KY and Mooney DJ, Hydrogels for tissue engineering. Chem Rev 101:1869-1879 (2001).
311. Jhon MS and Andrade JD, Water and Hydrogels. J Biomed Mater Res 7:509-522 (1973).
312. Ward JH and Peppas NA, Kinetic gelation modeling of controlled radical polymerizations. Macromolecules 33:5137-5142 (2000).
313. Jeon O, Bouhadir KH, Mansour JM and Alsberg E, Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials 30:2724-2734 (2009).
314. Chung C, Mesa J, Miller GJ, Randolph MA, Gill TJ and Burdick JA, Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks. Tissue Eng 12:2665-2673 (2006).
315. Almany L and Seliktar D, Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 26:2467-2477 (2005).
316. Elbert DL and Hubbell JA, Reduction of fibrous adhesion formation by a copolymer possessing an affinity for anionic surfaces. J Biomed Mater Res 42:55-65 (1998).
317. Stahl PJ, Romano NH, Wirtz D and Yu SM, PEG-based hydrogels with collagen mimetic peptide-mediated and tunable physical cross-links. Biomacromolecules 11:2336-2344 (2010).
318. Melrose J, Chuang C and Whitelock J, Tissue engineering log cartilages using biomatrices. J Chem Technol Biot 83:444-463 (2008).
319. Balakrishnan B and Banerjee R, Biopolymer-based hydrogels for cartilage tissue engineering. Chem Rev 111:4453-4474 (2011).
320. Ng KW, Ateshian GA and Hung CT, Zonal chondrocytes seeded in a layered agarose hydrogel create engineered cartilage with depth-dependent cellular and mechanical inhomogeneity. Tissue Eng Pt A 15:2315-2324 (2009).
321. Lu HH, Subramony SD, Boushell MK and Zhang XZ, Tissue engineering strategies for the regeneration of orthopedic interfaces. Ann Biomed Eng 38:2142-2154 (2010).
322. Chen JN, Chen HA, Li P, Diao HJ, Zhu SY, Dong L, et al., Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials 32:4793-4805 (2011).
323. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A and Peppas NA, Hydrogels in regenerative medicine. Adv Mater 21:3307-3329 (2009).
324. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG. Delivery of TGF-beta 1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26:7095-7103 (2005).
325. Bryant SJ and Anseth KS, The effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogels. Biomaterials 22:619-626 (2001).
326. Omidian H, Rocca JG and Park K, Advances in superporous hydrogels. J Control Release 102:3-12 (2005).
327. Bryant SJ, Anseth KS, Lee DA and Bader DL, Crosslinking density influences the morphology of chondrocytes photoencapsulated in PEG hydrogels during the application of compressive strain. J Orthopaed Res 22:1143-1149 (2004).
328. Xia F, Ge H, Hou Y, Sun TL, Chen L, Zhang GZ, et al., Multiresponsive surfaces change between superhydrophilicity and superhydrophobicity. Adv Mater 19:2520 (2007).
329. Peng T and Cheng YL, Temperature-responsive permeability of porous PNIPAAm-g-PE membranes. J Appl Polym Sci 70:2133-2142 (1998).
330. Lue SJ, Hsu JJ, Chen CH and Chen BC, Thermally on-off switching membranes of poly(N-isopropylacrylamide) immobilized in track-etched polycarbonate films. J Membrane Sci 301:142-150 (2007).
331. Kopecek J and Yang JY, Revie - hydrogels as smart biomaterials. Polym Int 56:1078-1098 (2007).
332. Nath N and Chilkoti A, Creating 'Smart' surfaces using stimuli responsive polymers. Adv Mater 14:1243 (2002).
333. Jeong B, Kim SW and Bae YH, Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliver Rev 54:37-51 (2002).
334. Joglekar M and Trewyn BG, Polymer-based stimuli-responsive nanosystems for biomedical applications. Biotechnol J 8:931-945 (2013).
335. Ju C, Sun J, Zi P, Jin X and Zhang C, Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel. J Pharm Sci 102:2707-2717 (2013).
336. Fleige E, Quadir MA and Haag R, Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 64:866-884 (2012).
337. Schild HG, Poly (N-Isopropylacrylamide) - experiment, theory and application. Prog Polym Sci 17:163-249 (1992).
338. Srivastava A and Kumar A, Thermoresponsive poly(N-vinylcaprolactam) cryogels: synthesis and its biophysical evaluation for tissue engineering applications. J Mater Sci Mater Med 21:2937-2945 (2010).
339. Ivanov AE, Galaev IY, Kazakov SV and Mattiasson B, Thermosensitive copolymers of N-vinylimidazole as displacers of proteins in immobilised metal affinity chromatography. J Chromatogr A 907:115-130 (2001).
340. Weber CH, R; Schubert, US. Temperature responsive bio-compatible polymers based on poly(ethylene oxide) and poly(2-oxazoline)s. Prog Polym Sci 37:686-714 (2012).
341. Niu G, Djaoui AB and Cohn D, Crosslinkable PEO-PPO-PEO triblocks as building blocks of thermo-responsive nanoshells. Polym Int 52:2524-2530 (2011).
342. Araujo JV, Davidenko N, Danner M, Cameron RE and Best SM, Novel porous scaffolds of pH responsive chitosan/carrageenan-based polyelectrolyte complexes for tissue engineering. J Biomed Mater Res A (2014).
343. Adrian Gestos PGW, Spinks GM and Wallace GG, Crosslinking neat ultrathin films and nanofibres of pH-responsive poly(acrylic acid) by UV radiation. Soft Matter 6:1045-1052 (2010).
344. Kyriakides TR, Cheung CY, Murthy N, Bornstein P, Stayton PS and Hoffman AS, pH-sensitive polymers that enhance intracellular drug delivery in vivo. J Control Release 78:295-303
345. Donini C, Robinson DN, Colombo P, Giordano F and Peppas NA, Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. Int J Pharm 245:83-91 (2002).